NDC 0409-2344 – Dobutamine
Dobutamine Hydrochloride 12.5 mg/mL · Injection, Solution, Concentrate · Intravenous
Product NDC0409-2344
Product details
- Brand name
- Dobutamine
- Generic name
- Dobutamine
- Labeler
- Hospira, Inc.
- Dosage form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Marketing category
- ANDA · ANDA074086
- Marketed since
- June 29, 2005
- Listing expires
- December 31, 2026
- Pharmacologic class
- beta-Adrenergic Agonist
Active ingredients
- Dobutamine Hydrochloride 12.5 mg/mL
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 0409-2344-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-2344-01) / 20 mL in 1 VIAL, SINGLE-DOSE | Aug 3, 2005 |
| 0409-2344-02 | 10 VIAL, SINGLE-DOSE in 1 TRAY (0409-2344-02) / 20 mL in 1 VIAL, SINGLE-DOSE (0409-2344-62) | Jun 29, 2005 |
| 0409-2344-88 | 10 VIAL, SINGLE-DOSE in 1 TRAY (0409-2344-88) / 20 mL in 1 VIAL, SINGLE-DOSE (0409-2344-68) | Apr 30, 2005 |
Recalls mentioning this NDC
- D-0489-2025 Jul 2, 2025 · Class II
Discoloration; discolored solution from cracked vials - D-1540-2014 Aug 27, 2014 · Class I
Presence of Particulate Matter: Discolored solution due to a chip in the glass at the neck of the vial, also glass particulate was found within the solution.
Other Dobutamine products
- 51662-1337 Dobutamine Hydrochloride 12.5 mg/mL · Injection, Solution, Concentrate · HF Acquisition Co LLC, DBA HealthFirst
- 0143-9141 Dobutamine Hydrochloride 12.5 mg/mL · Injection, Solution · Hikma Pharmaceuticals USA Inc.
- 70436-203 Dobutamine Hydrochloride 250 mg/20mL · Injection · Slate Run Pharmaceuticals